Navigation Links
CMC, Moffitt Partner to Study Cancer

CHARLOTTE, N.C., Feb. 26 /PRNewswire-USNewswire/ -- The Blumenthal Cancer Center at Carolinas Medical Center (CMC) in Charlotte is partnering with the Moffitt Cancer Center in a study that could lead to individualized treatments for specific types of cancer. CMC is the first hospital system outside Moffitt's home state of Florida to participate.

Over the next five years, CMC will enroll more than 2,300 patients in the study, which will involve collecting tissue samples, medical histories and clinical records. Participation in the study will enable Blumenthal Cancer Center patients to benefit from clinical trials and new treatments that may result from the research.

Cancers are often categorized by where they originate; for example, lung, breast, colon and prostate. However, the study, called Total Cancer Care, recognizes that there are more than 200 different types of cancer irrespective of where they first appear.

Each type has a specific molecular "fingerprint" made up of some 30,000 genes that could affect how it responds to different forms of treatment. By developing a data base of tissue samples from many cancer types, it may be possible to design individualized therapies that target the specific cancer, avoiding treatments that have little or no effect.

"The Total Cancer Care project is the kind of clinical research that physicians at Blumenthal Cancer Center are seeking for their patients," said Dr. Jeffrey Kneisl, medical director of Blumenthal Cancer Center and principal investigator for the Total Cancer Care study at CMC. "This is a thoughtfully conceived, methodically planned project that joins comprehensive cancer centers, cutting-edge research and patient-specific care."

Enrollment in the study is completely voluntary. If patients have cancer surgery, they will be asked to donate excess cancer tissues that would otherwise be discarded. If a biopsy is taken, researchers would like to obtain three to six additional samples for study.

Volunteers may be asked questions on a yearly basis about their medical history, diet and how they feel. If a new drug is developed that addresses their specific form of cancer, patients will be notified by researchers to see if they would be willing to participate in a clinical trial of that drug.

"Our vision is to integrate new technologies into the standard of care and improve outcomes of all cancer patients by partnering with outstanding health care institutions," said Dr. William Dalton, Moffitt President/CEO and Center Director. "We are also looking forward to collaborating with the physicians to increase access to new and improved therapies for cancer."

Located in Tampa, Florida, Moffitt Cancer Center ( is recognized by the National Cancer Institute as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia, and two in Puerto Rico.

Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer, as well as for ear, nose and throat. Moffitt's sole mission is to contribute to the prevention and cure of cancer.

The American College of Surgeons Commission on Cancer has designated CMC as an Accredited Network Cancer Program, one of just 26 hospital systems nationwide to achieve that level of accreditation.

Information on participating in the trial at CMC may be obtained by contacting Melanie Bamberg, program manager, at 704-355-6980 or

SOURCE Carolinas Medical Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
2. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
3. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
4. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
5. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
6. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
7. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
8. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
11. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
Post Your Comments:
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
Breaking Medicine News(10 mins):